In this study, CEBPA, RUNX1, BCORL1, and NF1 variants detected in young AML patients and WT1, KRAS, and JAK2 variants detected in elderly AML patients were consistent with the literature in diagnosis and risk stratification and disease follow-up. The gene discussed is NF1; the disease is acute myeloid leukemia.